← All companies
ALNY annual net income
ALNYLAM PHARMACEUTICALS, INC.
ALNY - CIK 0001178670
Market cap$38.62 B
Rank#396
SEC filings1,651
ALNYLAM PHARMACEUTICALS, INC. net income by year
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported net income of $313.75M for fiscal year 2025, as filed in its audited annual report with the SEC.
ALNY net income 2011-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $313.75M | +212.8% |
| FY 2024 | -$278.16M | +36.8% |
| FY 2023 | -$440.24M | +61.1% |
| FY 2022 | -$1.13B | -32.6% |
| FY 2021 | -$852.82M | +0.6% |
| FY 2020 | -$858.28M | +3.1% |
| FY 2019 | -$886.12M | -16.4% |
| FY 2018 | -$761.50M | -55.1% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does ALNYLAM PHARMACEUTICALS, INC. make?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported net income of $313.75M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has ALNYLAM PHARMACEUTICALS, INC.'s net income changed over time?
Between fiscal 2011 and fiscal 2025, ALNYLAM PHARMACEUTICALS, INC.'s net income grew from -$57.65M to $313.75M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.